Form 10-K405/A - Annual report [Sections 13 and 15(d), S-K Item 405]: [Amend]
SEC Accession No. 0001021408-01-504256
Filing Date
2001-07-31
Accepted
2001-07-31 00:00:00
Documents
2
Period of Report
2000-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 10-K d10k405a.txt 10-K405/A 86221
3 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.txt EX-23.1 615
  Complete submission text file 0001021408-01-504256.txt   88604
Mailing Address PO BOX 14287 PO BOX 14287 RESEARCH TRIANGLE PK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS- SUITE 200 RESEARCH TRIANGLE PK NC 27709 9195588688
INCARA PHARMACEUTICALS CORP (Filer) CIK: 0000936538 (see all company filings)

EIN.: 561924222 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K405/A | Act: 34 | File No.: 000-27410 | Film No.: 1693745
SIC: 2834 Pharmaceutical Preparations